To date the newest generation of anti-obesity drugs have either failed in clinical trials or have been rejected by the FDA due to lack of efficacy and/or the risk of unwanted side effects. It is…
(PRWeb August 12, 2010)
Read the full story at http://www.prweb.com/releases/2010/08/prweb4373604.htm